Salarius Pharmaceuticals's total assets for Q1 2025 were $2.34M, a decrease of -22.61% from the previous quarter. SLRX total liabilities were $2.28M for the fiscal quarter, a 50.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.